Top Markets
#1 Zora Zora +29.58%
#2 Tutorial Tutorial +26.36%
#3 Fabric Protocol Fabric Protocol +22.73%
#4 GALA GALA +21.84%
#5 The Black Bull The Black Bull +21.35%
#6 Derive Derive +20.87%
#7 Velvet Velvet +20.52%
#8 Useless Coin Useless Coin +20.20%
#9 Arowana Arowana +20.11%
#10 wojak wojak +20.11%
Coin of the day
Zora Zora
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Andros Pharmaceuticals Co.,Ltd Andros Pharmaceuticals Co.,Ltd

Andros Pharmaceuticals Co.,Ltd

6917
Classifica tra le azioni #24789
Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical enterprise,... Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the advancement of novel drug delivery platform technologies. Its development pipeline features APC101, a metered-dose, quick-drying, film-forming spray undergoing Phase IIa clinical investigation for the management of pain linked to post-herpetic neuralgia. Also in development is APC201, an innovative topical anesthetic formulation currently in Phase I/II trials for Osteoarthritis treatment, alongside an siRNA (small interfering RNA) compound functioning as an antisense oligonucleotide and DNA candidate. In the preclinical phase, the company is advancing APC310 and APC501, both intended as anesthetics for intravenous catheter insertion and venipuncture. Another preclinical asset, APC401, is a specialized emulsified solution targeting post-surgical pain relief. Beyond its developmental programs, Andros Pharmaceuticals also provides LALP cream for dermal analgesic use, iMinos solution for treating Alopecia Androgenetica, and T4 endonuclease V. Established in 2008, the firm maintains its headquarters in Zhubei, Taiwan.
Prezzo delle azioni
$1.03
Capitalizzazione di mercato
$56.61M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
80.30%
Paese
TW
Scambia Andros Pharmaceuticals Co.,Ltd (6917)

Categoria

Healthcare
Utile per Andros Pharmaceuticals Co.,Ltd (6917)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Andros Pharmaceuticals Co.,Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Andros Pharmaceuticals Co.,Ltd dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US